חזרה לתוצאות החיפוש

A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Myelofibrosis (MF)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Azienda Ospedaliero Universitaria Careggi Firenze, Struttura Complessa di Ematologia, Florence, Florence, Italy

    Contact: Study coordinator (Alessandro Vannucchi, Prof) · a.vannucchi@unifi.it · 0557947824 or : 0557947276
    Contact: Principal Investigator (Alessandro Vannucchi, Prof)

  • IRCCS Clinical Institute Humanitas, Rozzano, Milan, Italy

    Contact: Study coordinator (Armando Santoro, Prof) · armando.santoro@cancercenter.humanitas.it · +39 0282244080
    Contact: Principal Investigator (Armando Santoro, Prof)

  • Istituto di Ematolgia e Oncologia Medica, Bologna, Italy

    Contact: Study coordinator (Francesca Palandri, Prof) · francesca.palandri@unibo.it · +39512143044
    Contact: Principal Investigator (Francesca Palandri, Prof)

  • Istituto Romagnolo per lo Studio dei Tumori, Meldola, Italy

    Contact: Study coordinator (Alessandro Lucchesi, MD) · alessandro.lucchesi@irst.emr.it · 0039.0543.739292
    Contact: Principal Investigator (Alessandro Lucchesi)

  • Azienda Sanitario Universitaria Friuli Centrale, Udine, Italy

    Contact: Study coordinator (Mario Tiribelli, MD) · mario.tiribelli@uniud.it · +390342559662
    Contact: Principal Investigator (Mario Tiribelli, MD)

  • Vall d'Hebron University Hospital, Barcelona, Spain

    Contact: Study coordinator (Maria Laura Fox, MD) · mlfox@vhio.net · +34932746000
    Contact: Principal Investigator (Maria Laura Fox, MD)

  • Avigunda Gran via de l'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain

    Contact: Study coordinator (Jasson Andrés Villareal Hernández, Dr) · jvillarreal@iconcologia.net · +34 93 260 70 68
    Contact: Principal Investigator (Jasson Andrés Villareal Hernández, Dr)

  • START Madrid CIOCC, Madrid, Spain

    Contact: Study coordinator (Damian Cubillas, MD) · damian.cubillas@startmadrid.com

  • Hospital Universitario de Salamanca, Salamanca, Spain

    Contact: Study coordinator (Jesus Maria Hernandez Riva, MD) · jmhr@usal.es · +34 9232911000
    Contact: Principal Investigator (Jesus Maria Hernandez Rivas, MD)

  • United Lincolnshire Teach Hospitals NHS Trust, Pilgrim Hospital Boston, Boston, Lincolnshire, United Kingdom

    Contact: Study coordinator (Ciro Rinaldi, Prof) · crinaldi@nhs.net

  • Belfast City Hospital, Belfast, United Kingdom

    Contact: Study coordinator (Graeme Greenfield, MD) · Graeme.Greenfield@belfasttrust.hscni.net

  • Guy´s and St. Thomas NHS Foundation Trust, London, United Kingdom

    Contact: Study coordinator (Priya Sriskandarajah) · priya.sriskandarajah@nhs.net · MD
מובילי המחקר

  • Michael Lahn, Dr

    Study Director

    iOnctura

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)